134 related articles for article (PubMed ID: 34164520)
1. Attenuating glucose metabolism by
Wang HP; Chen WJ; Shen JM; Ye T; Xie HW
Ann Transl Med; 2021 May; 9(10):886. PubMed ID: 34164520
[TBL] [Abstract][Full Text] [Related]
2. Sensitization of colon cancer cells to cisplatin by Fbxw7 via negative regulation of the Nox1-mTOR pathway.
Huang G; Long K
Pathol Res Pract; 2023 Jul; 247():154479. PubMed ID: 37262995
[TBL] [Abstract][Full Text] [Related]
3. Interfering cellular lactate homeostasis overcomes Taxol resistance of breast cancer cells through the microRNA-124-mediated lactate transporter (MCT1) inhibition.
Hou L; Zhao Y; Song GQ; Ma YH; Jin XH; Jin SL; Fang YH; Chen YC
Cancer Cell Int; 2019; 19():193. PubMed ID: 31367191
[TBL] [Abstract][Full Text] [Related]
4. Blocking miR-27a-3p sensitises Taxol resistant osteosarcoma cells through targeting Fbxw7.
Lu B; Feng Z; Fan B; Shi Y
Bull Cancer; 2021 Jun; 108(6):596-604. PubMed ID: 33863546
[TBL] [Abstract][Full Text] [Related]
5. Curcumin Synergizes with Cisplatin to Inhibit Colon Cancer through Targeting the MicroRNA-137-Glutaminase Axis.
Fan WH; Wang FC; Jin Z; Zhu L; Zhang JX
Curr Med Sci; 2022 Feb; 42(1):108-117. PubMed ID: 34958454
[TBL] [Abstract][Full Text] [Related]
6. MiR-223 promotes the doxorubicin resistance of colorectal cancer cells via regulating epithelial-mesenchymal transition by targeting FBXW7.
Ding J; Zhao Z; Song J; Luo B; Huang L
Acta Biochim Biophys Sin (Shanghai); 2018 Jun; 50(6):597-604. PubMed ID: 29701752
[TBL] [Abstract][Full Text] [Related]
7. Nox1 promotes colon cancer cell metastasis via activation of the ADAM17 pathway.
Wang HP; Wang X; Gong LF; Chen WJ; Hao Z; Feng SW; Wu YB; Ye T; Cai YK
Eur Rev Med Pharmacol Sci; 2016 Nov; 20(21):4474-4481. PubMed ID: 27874952
[TBL] [Abstract][Full Text] [Related]
8. Nox1 is over-expressed in human colon cancers and correlates with activating mutations in K-Ras.
Laurent E; McCoy JW; Macina RA; Liu W; Cheng G; Robine S; Papkoff J; Lambeth JD
Int J Cancer; 2008 Jul; 123(1):100-7. PubMed ID: 18398843
[TBL] [Abstract][Full Text] [Related]
9. NADPH oxidase 1 is highly expressed in human large and small bowel cancers.
Lu J; Jiang G; Wu Y; Antony S; Meitzler JL; Juhasz A; Liu H; Roy K; Makhlouf H; Chuaqui R; Butcher D; Konaté MM; Doroshow JH
PLoS One; 2020; 15(5):e0233208. PubMed ID: 32428030
[TBL] [Abstract][Full Text] [Related]
10. LncRNA XIST Contributes to Cisplatin Resistance of Lung Cancer Cells by Promoting Cellular Glycolysis through Sponging miR-101-3p.
Hua G; Zeng ZL; Shi YT; Chen W; He LF; Zhao GF
Pharmacology; 2021; 106(9-10):498-508. PubMed ID: 34352791
[TBL] [Abstract][Full Text] [Related]
11. FBXW7 circular RNA regulates proliferation, migration and invasion of colorectal carcinoma through NEK2, mTOR, and PTEN signaling pathways in vitro and in vivo.
Lu H; Yao B; Wen X; Jia B
BMC Cancer; 2019 Sep; 19(1):918. PubMed ID: 31519156
[TBL] [Abstract][Full Text] [Related]
12. Exosomal transfer of circular RNA FBXW7 ameliorates the chemoresistance to oxaliplatin in colorectal cancer by sponging miR-18b-5p.
Xu Y; Qiu A; Peng F; Tan X; Wang J; Gong X
Neoplasma; 2021 Jan; 68(1):108-118. PubMed ID: 33147048
[TBL] [Abstract][Full Text] [Related]
13. Exosomes derived from Taxol-resistant nasopharyngeal carcinoma (NPC) cells transferred DDX53 to NPC cells and promoted cancer resistance to Taxol.
Yuan F; Zhou ZF
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):127-138. PubMed ID: 33506900
[TBL] [Abstract][Full Text] [Related]
14. FBP1 enhances the radiosensitivity by suppressing glycolysis via the FBXW7/mTOR axis in nasopharyngeal carcinoma cells.
Zhang P; Shao Y; Quan F; Liu L; Yang J
Life Sci; 2021 Oct; 283():119840. PubMed ID: 34298040
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-4 and interleukin-13 increase NADPH oxidase 1-related proliferation of human colon cancer cells.
Liu H; Antony S; Roy K; Juhasz A; Wu Y; Lu J; Meitzler JL; Jiang G; Polley E; Doroshow JH
Oncotarget; 2017 Jun; 8(24):38113-38135. PubMed ID: 28498822
[TBL] [Abstract][Full Text] [Related]
16. NAD(P)H oxidase 1, a product of differentiated colon epithelial cells, can partially replace glycoprotein 91phox in the regulated production of superoxide by phagocytes.
Geiszt M; Lekstrom K; Brenner S; Hewitt SM; Dana R; Malech HL; Leto TL
J Immunol; 2003 Jul; 171(1):299-306. PubMed ID: 12817011
[TBL] [Abstract][Full Text] [Related]
17. FBXW7 mediates chemotherapeutic sensitivity and prognosis in NSCLCs.
Yokobori T; Yokoyama Y; Mogi A; Endoh H; Altan B; Kosaka T; Yamaki E; Yajima T; Tomizawa K; Azuma Y; Onozato R; Miyazaki T; Tanaka S; Kuwano H
Mol Cancer Res; 2014 Jan; 12(1):32-7. PubMed ID: 24165483
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of miR-203 sensitizes paclitaxel (Taxol)-resistant colorectal cancer cells through targeting the salt-inducible kinase 2 (SIK2).
Liu Y; Gao S; Chen X; Liu M; Mao C; Fang X
Tumour Biol; 2016 Sep; 37(9):12231-12239. PubMed ID: 27236538
[TBL] [Abstract][Full Text] [Related]
19. lncRNA NEAT1 promotes the Taxol resistance of breast cancer via sponging the miR-23a-3p-FOXA1 axis.
Zhu L; Wang F; Fan W; Jin Z; Teng C; Zhang J
Acta Biochim Biophys Sin (Shanghai); 2021 Aug; 53(9):1198-1206. PubMed ID: 34327529
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 10 inhibits interferon gamma- and tumor necrosis factor alpha-stimulated activation of NADPH oxidase 1 in human colonic epithelial cells and the mouse colon.
Kamizato M; Nishida K; Masuda K; Takeo K; Yamamoto Y; Kawai T; Teshima-Kondo S; Tanahashi T; Rokutan K
J Gastroenterol; 2009; 44(12):1172-84. PubMed ID: 19714290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
